$0.0470
0.0129.83%
At close: -
$0.0450
-0.00200-4.26%
After Hours: Dec 20, 7:15 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Bristol-Myers Squibb Company Celegne Contingent Value Rights in recent months.
Browse guidance and forecast on all stocks.